|
SLC38A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.96950999999945E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.94220000000157E-05 |
| Normal-vs-Stage2 |
3.542800E-03 |
| Normal-vs-Stage3 |
1.579120E-03 |
| Normal-vs-Stage4 |
1.417200E-03 |
| Stage1-vs-Stage2 |
9.713200E-01 |
| Stage1-vs-Stage3 |
9.587600E-01 |
| Stage1-vs-Stage4 |
8.295600E-01 |
| Stage2-vs-Stage3 |
9.928800E-01 |
| Stage2-vs-Stage4 |
8.558000E-01 |
| Stage3-vs-Stage4 |
8.362000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.59589999998633E-06 |
| Normal-vs-AfricanAmerican |
3.933800E-01 |
| Normal-vs-Asian |
2.267200E-01 |
| Caucasian-vs-AfricanAmerican |
1.738780E-03 |
| Caucasian-vs-Asian |
7.289800E-01 |
| AfricanAmerican-vs-Asian |
3.233800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55756999999923E-05 |
| Normal-vs-Female |
1.822830E-03 |
| Male-vs-Female |
2.574000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.118200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.021010E-04 |
| Normal-vs-Age(61-80Yrs) |
5.87199999999566E-05 |
| Normal-vs-Age(81-100Yrs) |
4.068800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.215000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.622400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.273000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.926000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.333800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.870000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.635800E-01 |
| Normal-vs-Grade 2 |
1.79316999999735E-05 |
| Normal-vs-Grade 3 |
9.91519999999912E-05 |
| Normal-vs-Grade 4 |
2.598300E-02 |
| Grade 1-vs-Grade 2 |
1.081760E-01 |
| Grade 1-vs-Grade 3 |
1.947020E-01 |
| Grade 1-vs-Grade 4 |
7.941200E-01 |
| Grade 2-vs-Grade 3 |
5.720000E-01 |
| Grade 2-vs-Grade 4 |
1.258030E-01 |
| Grade 3-vs-Grade 4 |
2.422800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.07279999999699E-05 |
| Normal-vs-ccB subtype |
1.55011999999344E-05 |
| ccA subtype-vs-ccB subtype |
3.861400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.036410E-04 |
| Normal-vs-N1 |
3.636400E-02 |
| N0-vs-N1 |
1.904580E-01 |
|
|
